Skip to content
Research Article Open access CC BY 4.0

Comparison of the Prognosis and Mortality of Sars-Cov-2 Variants in Critically İll Patients

Sinem Bayrakci

Asian Journal of Research in Infectious Diseases · pp. 26–33 · Published 18 Sep 2023

10.9734/ajrid/2023/v14i3295

Abstract

Backround: Since the beginning of the pandemic,the globally circulation of SARS-CoV-2 has caused the virus to constantly mutate,resulting in the emergence of new variants.Some of these variants have been designated as variants of concern(VOC),defined by the WHO as variants associated with increased infectivity,increased disease severity,or change in clinical disease presentation. Aim and Objective: We aimed  to evaluate and compare the prognosis and mortality of the critically ill patients infected with SARS-CoV-2 and SARS-CoV-2 variants. Materials and Methods: A total of 335 critically ill patient who were positive for SARS-CoV-2 by polymerase chain reaction enrolled in the study. Results: Hypertension was significantly higher in the patients in delta group(p=0,02).The presence of comorbidity was statistically significantly associated with mortality in all groups(p <0,05). Unvaccinated patients were significantly higher in all groups and being unvaccinated was associated with mortality in all groups(p <0,05).Mortality was statistically significantly associated with all groups(p=0,01).The delta variant poses a higher risk of mortality compared to other variants(p=0,0001). Conclusion: The study indicates that severe disease requiring intensive care admission were common in the elderly.Hypertension was higher in the patients in delta group and the presence of comorbidity was associated with mortality in all variant types of COVID-19.Severe disease requiring intensive care admission was more common in the unvaccinated population, regardless of variant type, and being unvaccinated was associated with mortality.All variant types were associated with mortality, but the mortality risk was higher in patients infected with delta variant compared to other variants.

COVID-19 variants of concern mortality prognosis unvaccinated

References (25)

  1. 1 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [DOI]
  2. 2 WHO Declares COVID-19 a Pandemic. [DOI]
  3. 3 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England [DOI]
  4. 4 Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission [DOI]
  5. 5 Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study [DOI]
  6. 6 Management of COVID-19 Respiratory Distress [DOI]
  7. 7 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness [DOI]
  8. 8 Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants [DOI]
  9. 9 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study [DOI]
  10. 10 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant [DOI]
  11. 11 Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada [DOI]
  12. 12 Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study [DOI]
  13. 13 AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19 [DOI]
  14. 14 Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis [DOI]
  15. 15 Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals [DOI]
  16. 16 Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study [DOI]
  17. 17 Outcomes of COVID-19 patients with comorbidities in southwest Nigeria [DOI]
  18. 18 Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study [DOI]
  19. 19 Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea: Experience from Gyeongsangnam-do [DOI]
  20. 20 Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients? [DOI]
  21. 21 The Dominance of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 and Its Sublineages and Associations with Mortality during the COVID-19 Pandemic in India between 2020 and 2021 [DOI]
  22. 22 CT Score and Prognosis of Vaccinated and Unvaccinated Patients in COVID 19 Pneumonia [DOI]
  23. 23 Covid-19: New coronavirus variant is identified in UK [DOI]
  24. 24 Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta) [DOI]
  25. 25 Paying attention to patient self-inflicted lung injury [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

31

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.